Foreign body contamination in pharmaceutical products can pose a major threat to patient health and can have severe consequences. For example, discarding entire product batches and extending production line down time during root cause investigation can result in costly delays.

Working to GMP standards, RSSL’s state-of-the-art laboratories and experienced team of scientists can identify foreign materials in pharmaceutical raw materials, process intermediates and finished products. Crucially, we can analyse foreign matter in the whole range of pharmaceutical matrices, including powders, tablets, capsules and creams, using a range of specialised techniques.